Xeris Biopharma Holdings XERS Earnings Call Transcripts

NASDAQ XERS
$16.52 +0.69 (+4.36%)
At close: Nov 11, 2026 · 4:00 PM EST
9 earnings calls on file for Xeris Biopharma Holdings, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Xeris Biopharma Holdings Q3 2026 Earnings Call

Nov 5, 2026 4,340 words · 19 min read
  • John ShannonChairman and Chief Executive Officer
  • Steve PieperChief Financial Officer
  • Cristi BarnettVice President of Investor Relations
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Xeris Biopharma Holdings Earnings Call Transcripts

Calls9
LatestNov 5, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2020

Fiscal 2019

All 9 Xeris Biopharma Holdings transcripts Register to get access to Xeris Biopharma Holdings’s earnings call transcripts.